CN Stock MarketDetailed Quotes

300558 Betta Pharmaceuticals

Watchlist
  • 37.34
  • 0.000.00%
Market Closed Sep 6 15:00 CST
15.63BMarket Cap36.90P/E (TTM)

Betta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
14.22%1.5B
38.40%735.78M
3.35%2.46B
22.90%2.04B
4.83%1.31B
-9.08%531.62M
5.82%2.38B
-3.58%1.66B
8.50%1.25B
-5.47%584.71M
Operating revenue
14.22%1.5B
38.40%735.78M
3.35%2.46B
22.90%2.04B
4.83%1.31B
-9.08%531.62M
5.82%2.38B
-3.58%1.66B
8.50%1.25B
-5.47%584.71M
Other operating revenue
-26.39%14.29M
----
15.30%39.41M
----
12.32%19.41M
----
-14.65%34.18M
----
-13.61%17.28M
----
Total operating cost
2.53%1.26B
20.78%641.56M
-7.60%2.21B
12.16%1.81B
1.22%1.23B
6.49%531.2M
26.21%2.4B
17.62%1.61B
32.13%1.22B
9.71%498.84M
Operating cost
16.69%242.27M
64.26%128.54M
50.54%404.48M
54.43%293.32M
49.61%207.62M
11.10%78.26M
54.04%268.69M
52.54%189.93M
64.63%138.77M
78.98%70.44M
Operating tax surcharges
8.18%9.86M
31.55%5.11M
-19.76%14.07M
21.87%13.81M
20.44%9.11M
-14.95%3.89M
15.42%17.53M
20.18%11.33M
29.64%7.56M
390.24%4.57M
Operating expense
14.37%523.71M
49.54%230.48M
9.61%853.89M
44.74%709.52M
3.99%457.91M
-14.68%154.12M
-4.38%779.06M
-26.30%490.18M
-1.10%440.33M
-23.22%180.64M
Administration expense
3.67%211.13M
12.68%114.73M
-42.49%261.76M
-31.91%292.17M
-34.17%203.65M
-23.49%101.82M
39.28%455.16M
109.40%429.06M
116.90%309.35M
108.92%133.08M
Financial expense
3.92%18.13M
-43.99%9.95M
-77.45%39.59M
304.65%28.36M
658.59%17.44M
616.74%17.76M
14,357.73%175.57M
696.78%7.01M
369.83%2.3M
185.80%2.48M
-Interest expense (Financial expense)
-25.75%22.28M
-43.59%11.01M
-71.93%54.95M
70.71%42.19M
115.58%30M
368.75%19.51M
1,140.90%195.8M
107.02%24.71M
75.65%13.92M
3.00%4.16M
-Interest Income (Financial expense)
21.27%-3.96M
22.05%-2.64M
5.95%-10.23M
2.47%-7.33M
0.76%-5.03M
-29.09%-3.39M
40.84%-10.88M
42.66%-7.52M
46.37%-5.07M
50.06%-2.62M
Research and development
-23.39%256.28M
-12.89%152.75M
-8.54%640.14M
-2.90%467.94M
5.50%334.52M
62.91%175.36M
23.67%699.9M
31.84%481.92M
30.65%317.07M
-9.03%107.64M
Credit Impairment Loss
380.40%6.82M
232.75%5.07M
-252.67%-8.8M
-5.59%-7.89M
46.85%-2.43M
-2,102.40%-3.82M
-292.30%-2.5M
-1,177.59%-7.48M
-9,504.39%-4.58M
-73.79%-173.55K
Asset Impairment Loss
----
----
----
----
----
----
---3.52M
----
----
----
Other net revenue
415.35%14.49M
218.01%14.15M
-75.64%27.79M
-103.50%-1.42M
-92.49%2.81M
-60.21%4.45M
137.46%114.09M
48.82%40.7M
61.42%37.44M
16.13%11.18M
Fair value change income
----
----
68.91%-312.61K
----
----
----
-200.00%-1.01M
---1.01M
-143.44%-1.01M
---1.01M
Invest income
50.07%-5.18M
-76.11%-2.15M
31.90%-13.36M
-3,550.74%-14.68M
-5,844.18%-10.38M
-217.84%-1.22M
-231.12%-19.61M
-103.58%-402.06K
-97.23%180.74K
-51.29%1.04M
-Including: Investment income associates
50.07%-5.18M
-76.11%-2.15M
33.79%-13.99M
-675.60%-14.68M
-692.73%-10.38M
-169.51%-1.22M
-4,072.95%-21.12M
---1.89M
---1.31M
---453.42K
Asset deal income
-1,722.04%-6.19M
-14,919.64%-1.77M
-100.01%-10.73K
-1,041.05%-1.03M
-267.06%-339.65K
83.26%-11.79K
130,084.94%88.61M
4.61%109.45K
89.60%203.31K
-165.00%-70.45K
Other revenue
19.28%19.04M
36.73%13M
-3.53%50.27M
-55.17%22.18M
-62.55%15.97M
-16.57%9.5M
59.61%52.11M
198.28%49.47M
198.47%42.64M
52.11%11.39M
Operating profit
193.72%253.89M
2,128.02%108.36M
184.89%270.07M
152.17%237.02M
14.66%86.44M
-94.99%4.86M
-76.04%94.8M
-75.49%93.99M
-70.84%75.39M
-44.07%97.04M
Add:Non operating Income
-99.64%215.27K
----
2,629.24%61.58M
2,141.33%59.8M
2,834.84%59.78M
5,334.45%33.39M
-16.44%2.26M
0.90%2.67M
-20.78%2.04M
302,106.92%614.42K
Less:Non operating expense
0.19%4.02M
-58.83%1.13M
1.00%9.58M
-22.77%5.04M
-24.04%4.02M
48.99%2.75M
13.25%9.48M
-8.02%6.52M
-5.71%5.29M
75.55%1.85M
Total profit
75.86%250.08M
202.02%107.23M
267.79%322.07M
223.70%291.78M
97.13%142.21M
-62.94%35.5M
-77.54%87.57M
-76.22%90.14M
-71.77%72.14M
-44.44%95.81M
Less:Income tax cost
5,293.30%33.96M
208.03%13.44M
68.97%-11.54M
-272.67%-2.34M
104.46%629.65K
-175.22%-12.44M
-458.76%-37.19M
-96.28%1.35M
-132.68%-14.11M
-36.29%16.54M
Net profit
52.65%216.12M
95.64%93.79M
167.40%333.62M
231.27%294.12M
64.14%141.58M
-39.52%47.94M
-67.13%124.76M
-74.09%88.79M
-59.38%86.25M
-45.88%79.27M
Net profit from continuing operation
52.65%216.12M
95.64%93.79M
167.40%333.62M
231.27%294.12M
64.14%141.58M
-39.52%47.94M
-67.13%124.76M
-74.09%88.79M
-59.38%86.25M
--79.27M
Less:Minority Profit
-16.27%-7.82M
-25.89%-4.35M
30.21%-14.42M
24.61%-10.57M
20.50%-6.73M
21.58%-3.46M
-489.00%-20.66M
-236.77%-14.02M
-205.78%-8.46M
-249.17%-4.41M
Net profit of parent company owners
51.00%223.95M
90.95%98.14M
139.33%348.03M
196.38%304.69M
56.58%148.31M
-38.58%51.4M
-62.04%145.42M
-70.36%102.81M
-55.96%94.72M
-43.36%83.68M
Earning per share
Basic earning per share
50.00%0.54
91.67%0.23
137.14%0.83
192.00%0.73
56.52%0.36
-40.00%0.12
-61.96%0.35
-70.24%0.25
-55.77%0.23
-44.44%0.2
Diluted earning per share
54.29%0.54
91.67%0.23
137.14%0.83
192.00%0.73
52.17%0.35
-40.00%0.12
-61.96%0.35
-69.51%0.25
-55.77%0.23
-42.86%0.2
Other composite income
-57.10%14.55M
507.29%147.49M
14.85%60.76M
-83.45%8.43M
2,169.06%33.93M
-35.76%-36.21M
127.40%52.9M
-33.45%50.94M
-98.20%1.5M
-2,413.96%-26.67M
Other composite income of parent company owners
-57.10%14.55M
507.29%147.49M
14.85%60.76M
-83.45%8.43M
2,169.06%33.93M
-35.76%-36.21M
127.40%52.9M
-33.45%50.94M
-98.20%1.5M
-2,413.96%-26.67M
Total composite income
31.44%230.68M
1,957.23%241.28M
121.98%394.37M
116.53%302.56M
100.01%175.5M
-77.70%11.73M
-55.90%177.66M
-66.67%139.73M
-70.29%87.75M
-63.83%52.6M
Total composite income of parent company owners
30.88%238.5M
1,517.73%245.63M
106.12%408.79M
103.66%313.13M
89.41%182.23M
-73.36%15.18M
-51.19%198.32M
-63.69%153.75M
-67.73%96.21M
-61.14%57M
Total composite income of minority owners
-16.27%-7.82M
-25.89%-4.35M
30.21%-14.42M
24.61%-10.57M
20.50%-6.73M
21.58%-3.46M
-489.00%-20.66M
-236.77%-14.02M
-205.78%-8.46M
-249.17%-4.41M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 14.22%1.5B38.40%735.78M3.35%2.46B22.90%2.04B4.83%1.31B-9.08%531.62M5.82%2.38B-3.58%1.66B8.50%1.25B-5.47%584.71M
Operating revenue 14.22%1.5B38.40%735.78M3.35%2.46B22.90%2.04B4.83%1.31B-9.08%531.62M5.82%2.38B-3.58%1.66B8.50%1.25B-5.47%584.71M
Other operating revenue -26.39%14.29M----15.30%39.41M----12.32%19.41M-----14.65%34.18M-----13.61%17.28M----
Total operating cost 2.53%1.26B20.78%641.56M-7.60%2.21B12.16%1.81B1.22%1.23B6.49%531.2M26.21%2.4B17.62%1.61B32.13%1.22B9.71%498.84M
Operating cost 16.69%242.27M64.26%128.54M50.54%404.48M54.43%293.32M49.61%207.62M11.10%78.26M54.04%268.69M52.54%189.93M64.63%138.77M78.98%70.44M
Operating tax surcharges 8.18%9.86M31.55%5.11M-19.76%14.07M21.87%13.81M20.44%9.11M-14.95%3.89M15.42%17.53M20.18%11.33M29.64%7.56M390.24%4.57M
Operating expense 14.37%523.71M49.54%230.48M9.61%853.89M44.74%709.52M3.99%457.91M-14.68%154.12M-4.38%779.06M-26.30%490.18M-1.10%440.33M-23.22%180.64M
Administration expense 3.67%211.13M12.68%114.73M-42.49%261.76M-31.91%292.17M-34.17%203.65M-23.49%101.82M39.28%455.16M109.40%429.06M116.90%309.35M108.92%133.08M
Financial expense 3.92%18.13M-43.99%9.95M-77.45%39.59M304.65%28.36M658.59%17.44M616.74%17.76M14,357.73%175.57M696.78%7.01M369.83%2.3M185.80%2.48M
-Interest expense (Financial expense) -25.75%22.28M-43.59%11.01M-71.93%54.95M70.71%42.19M115.58%30M368.75%19.51M1,140.90%195.8M107.02%24.71M75.65%13.92M3.00%4.16M
-Interest Income (Financial expense) 21.27%-3.96M22.05%-2.64M5.95%-10.23M2.47%-7.33M0.76%-5.03M-29.09%-3.39M40.84%-10.88M42.66%-7.52M46.37%-5.07M50.06%-2.62M
Research and development -23.39%256.28M-12.89%152.75M-8.54%640.14M-2.90%467.94M5.50%334.52M62.91%175.36M23.67%699.9M31.84%481.92M30.65%317.07M-9.03%107.64M
Credit Impairment Loss 380.40%6.82M232.75%5.07M-252.67%-8.8M-5.59%-7.89M46.85%-2.43M-2,102.40%-3.82M-292.30%-2.5M-1,177.59%-7.48M-9,504.39%-4.58M-73.79%-173.55K
Asset Impairment Loss ---------------------------3.52M------------
Other net revenue 415.35%14.49M218.01%14.15M-75.64%27.79M-103.50%-1.42M-92.49%2.81M-60.21%4.45M137.46%114.09M48.82%40.7M61.42%37.44M16.13%11.18M
Fair value change income --------68.91%-312.61K-------------200.00%-1.01M---1.01M-143.44%-1.01M---1.01M
Invest income 50.07%-5.18M-76.11%-2.15M31.90%-13.36M-3,550.74%-14.68M-5,844.18%-10.38M-217.84%-1.22M-231.12%-19.61M-103.58%-402.06K-97.23%180.74K-51.29%1.04M
-Including: Investment income associates 50.07%-5.18M-76.11%-2.15M33.79%-13.99M-675.60%-14.68M-692.73%-10.38M-169.51%-1.22M-4,072.95%-21.12M---1.89M---1.31M---453.42K
Asset deal income -1,722.04%-6.19M-14,919.64%-1.77M-100.01%-10.73K-1,041.05%-1.03M-267.06%-339.65K83.26%-11.79K130,084.94%88.61M4.61%109.45K89.60%203.31K-165.00%-70.45K
Other revenue 19.28%19.04M36.73%13M-3.53%50.27M-55.17%22.18M-62.55%15.97M-16.57%9.5M59.61%52.11M198.28%49.47M198.47%42.64M52.11%11.39M
Operating profit 193.72%253.89M2,128.02%108.36M184.89%270.07M152.17%237.02M14.66%86.44M-94.99%4.86M-76.04%94.8M-75.49%93.99M-70.84%75.39M-44.07%97.04M
Add:Non operating Income -99.64%215.27K----2,629.24%61.58M2,141.33%59.8M2,834.84%59.78M5,334.45%33.39M-16.44%2.26M0.90%2.67M-20.78%2.04M302,106.92%614.42K
Less:Non operating expense 0.19%4.02M-58.83%1.13M1.00%9.58M-22.77%5.04M-24.04%4.02M48.99%2.75M13.25%9.48M-8.02%6.52M-5.71%5.29M75.55%1.85M
Total profit 75.86%250.08M202.02%107.23M267.79%322.07M223.70%291.78M97.13%142.21M-62.94%35.5M-77.54%87.57M-76.22%90.14M-71.77%72.14M-44.44%95.81M
Less:Income tax cost 5,293.30%33.96M208.03%13.44M68.97%-11.54M-272.67%-2.34M104.46%629.65K-175.22%-12.44M-458.76%-37.19M-96.28%1.35M-132.68%-14.11M-36.29%16.54M
Net profit 52.65%216.12M95.64%93.79M167.40%333.62M231.27%294.12M64.14%141.58M-39.52%47.94M-67.13%124.76M-74.09%88.79M-59.38%86.25M-45.88%79.27M
Net profit from continuing operation 52.65%216.12M95.64%93.79M167.40%333.62M231.27%294.12M64.14%141.58M-39.52%47.94M-67.13%124.76M-74.09%88.79M-59.38%86.25M--79.27M
Less:Minority Profit -16.27%-7.82M-25.89%-4.35M30.21%-14.42M24.61%-10.57M20.50%-6.73M21.58%-3.46M-489.00%-20.66M-236.77%-14.02M-205.78%-8.46M-249.17%-4.41M
Net profit of parent company owners 51.00%223.95M90.95%98.14M139.33%348.03M196.38%304.69M56.58%148.31M-38.58%51.4M-62.04%145.42M-70.36%102.81M-55.96%94.72M-43.36%83.68M
Earning per share
Basic earning per share 50.00%0.5491.67%0.23137.14%0.83192.00%0.7356.52%0.36-40.00%0.12-61.96%0.35-70.24%0.25-55.77%0.23-44.44%0.2
Diluted earning per share 54.29%0.5491.67%0.23137.14%0.83192.00%0.7352.17%0.35-40.00%0.12-61.96%0.35-69.51%0.25-55.77%0.23-42.86%0.2
Other composite income -57.10%14.55M507.29%147.49M14.85%60.76M-83.45%8.43M2,169.06%33.93M-35.76%-36.21M127.40%52.9M-33.45%50.94M-98.20%1.5M-2,413.96%-26.67M
Other composite income of parent company owners -57.10%14.55M507.29%147.49M14.85%60.76M-83.45%8.43M2,169.06%33.93M-35.76%-36.21M127.40%52.9M-33.45%50.94M-98.20%1.5M-2,413.96%-26.67M
Total composite income 31.44%230.68M1,957.23%241.28M121.98%394.37M116.53%302.56M100.01%175.5M-77.70%11.73M-55.90%177.66M-66.67%139.73M-70.29%87.75M-63.83%52.6M
Total composite income of parent company owners 30.88%238.5M1,517.73%245.63M106.12%408.79M103.66%313.13M89.41%182.23M-73.36%15.18M-51.19%198.32M-63.69%153.75M-67.73%96.21M-61.14%57M
Total composite income of minority owners -16.27%-7.82M-25.89%-4.35M30.21%-14.42M24.61%-10.57M20.50%-6.73M21.58%-3.46M-489.00%-20.66M-236.77%-14.02M-205.78%-8.46M-249.17%-4.41M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg